These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6352651)

  • 1. Ceftazidime: aspects of efficacy and tolerance.
    Foord RD
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():399-403. PubMed ID: 6352651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime in clinical practice - a summary.
    Norrby SR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():405-8. PubMed ID: 6352652
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftazidime in severe infections: a Swiss multicentre study.
    Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime in clinical practice.
    Alestig K; Eilard T; Norrby R; Svensson R; Trollfors B; Brorson JE
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():111-4. PubMed ID: 6225759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.
    Clumeck N; Van Laethem Y; Gordts B; Jaspar N; Butzler JP
    Antimicrob Agents Chemother; 1983 Aug; 24(2):176-80. PubMed ID: 6357068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime in the treatment of febrile immunosuppressed children.
    Darbyshire PJ; Williamson PJ; Pedler SJ; Speller DC; Mott MG; Oakhill A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():357-60. PubMed ID: 6352644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of bone infections with ceftazidime.
    Dutoy JP; Wauters G
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():229-33. PubMed ID: 6352624
    [No Abstract]   [Full Text] [Related]  

  • 8. Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.
    Clumeck N; Gordts B; Dab I; Jaspar N; Van Laethem Y; Butzler JP
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():207-11. PubMed ID: 6352620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies on ceftazidime in surgery in Japan.
    Nakayama I
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():377-81. PubMed ID: 6352648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of ceftazidime in internal medicine in Japan.
    Shimada K
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():395-7. PubMed ID: 6225765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime therapy for serious infections.
    Bint AJ; Constable J; Patton KR; Constable FL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection.
    Gentry LO; Douthit MB; Childs SJ; Madsen PO
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():53-7. PubMed ID: 6352655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open study of ceftazidime in the treatment of serious bacterial infection.
    Allan SG; Glover SC; Smith CC; Hadley KM; Reid TM; Han K; Murdoch JM; Ingram PM
    J Antimicrob Chemother; 1983 Sep; 12(3):219-27. PubMed ID: 6355044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime treatment in intensive care patients.
    van Dalen R; Muytjens HL; Gimbrère JS
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():189-97. PubMed ID: 6225763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa.
    Maslow MJ; Rosenberg A; Pollock AA; Press RA; Silverman D; El-Sadr W; Richmond AS; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():213-7. PubMed ID: 6413486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients].
    de Pauw BE
    Infection; 1987; 15 Suppl 4():S168-72. PubMed ID: 3312029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients.
    Walstad RA; Hellum KB; Svarva PL; Ingram PM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():131-7. PubMed ID: 6352614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
    Pechère JC; Delisle R
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():181-8. PubMed ID: 6352619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.